Noteworthy Friday Option Activity: BRZE, APLS, SOUN

Apellis (APLS) options activity shows 16,269 contracts traded today (~1.6M underlying shares), equal to roughly 69.7% of its one‑month ADV (2.3M shares), led by 7,553 contracts in the $25 put expiring Jan 16, 2026 (~755,300 shares). SoundHound AI (SOUN) saw 139,006 option contracts (~13.9M shares), about 62.1% of its one‑month ADV (22.4M shares), with notable activity in 14,680 contracts of the $12 call expiring Jan 9, 2026 (~1.5M shares). The concentration in single strikes suggests heightened speculative positioning that could drive intraday volatility in each security.

Analysis

Market structure: The concentrated options flow is a directional funding event: APLS $25 Jan 16, 2026 puts (7,553 contracts ≈755k shares, ~33% of ADV) signal sizeable downside demand that will force dealers to hedge by selling stock into the tape, increasing near‑term supply pressure. SOUN’s $12 Jan 09, 2026 calls (14,680 contracts ≈1.47M shares, smaller % of its 22.4M ADV) create asymmetric buy‑pressure from dealer delta-hedging that can amplify intraday rallies; overall options volume equals ~69.7% (APLS) and ~62.1% (SOUN) of ADV, meaning transient liquidity impacts are material for both names.

Risk assessment: Key tail risks include a biotech/FDA binary for APLS or a corporate partnership/earnings surprise for SOUN that would blow the current directional flow wider; dealer gamma exhaustion could produce 10–30% intraday gaps on expiries. Time horizons: immediate (hours–days) — delta hedging into expiries; short term (weeks–3 months) — re‑pricing of IV and stock moves as positions roll; long term (quarters+) — fundamentals reassert (clinical data or AI revenue traction). Monitor IV spikes >20% and unusual increases in OI as alerts.

Trade implications: For APLS, prefer defined‑risk bearish structures: buy Jan16,2026 25/20 put debit spread (entry if mid IV ≤ +15% vs 30‑day average), sized 1–2% portfolio notional, target >20% return if stock < $22 by expiry. For SOUN, avoid being short final‑day calls; consider a short‑dated momentum entry: buy shares or buy-to-open Jan‑expiring $12 calls only if price breaks +10% on >2x intraday ADV, size 0.5–1% and trim at +20% move. Use IV crush into expiry to sell premium on names where IV is +30% vs historical.

Contrarian angles: The market may be misreading protective hedges as pure directional conviction — large put blocks can be hedge overlay for convertible or institutional longs and may not signal fundamental deterioration. If APLS holds above $30 and IV collapses >25% over 7 trading days, that is a contrarian buy signal; conversely, if SOUN’s price fails to follow call flows (no >5% move within 48h of the trade), consider selling short-term calls into the exhaustion. Track short interest (>10%) and change in dealer OI weekly as a confirmatory filter.

Key Decisions for Investors

• Establish a 1–2% portfolio notional long APLS Jan16,2026 25/20 put debit spread (defined risk) if mid IV ≤ +15% above 30‑day average; target payoff if APLS < $22 by expiry, stop‑loss: IV rise that doubles spread cost or price > $28.
• Avoid shorting SOUN into today’s expiries; if SOUN gaps up +10% on >2x ADV, initiate a 0.5–1% long equity position or buy-to-open Jan‑09,2026 $12 calls intraday and take profits at +20% move or lock 50% at +10%.
• If APLS price holds above $30 and IV falls >25% within 7 trading days, flip to a tactical 0.5–1% long equity position (mean‑reversion/short squeeze play); exit if price < $28 on renewed IV surge.
• Monitor three metrics daily for both tickers for 14 days: (1) net change in options open interest (>15% change), (2) IV change vs 30‑day historic (>+20% alert), (3) stock volume relative to ADV (>2x); act only when two of three confirm before adding exposure.